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ABSTRACT                        Two-pore domain potassium channels (K2P) control excitability, stabilize the resting 
membrane potential below firing threshold, and accelerate repolarisation in different cells. Until 
now, fifteen different genes for the six K2P channel subfamily were cloned. The pore-forming 
part is translated from two genes and they are built up from a dimer of two two-unit trans-
membrane domains functioning with a wide spectrum of physiological profiles. K2P ion channels 
were discovered in the last two decades and gave novel opportunity to recognize the complex 
molecular mechanism of the potassium ion flux, and may lead to the design of individual drug 
targeting in the future. In this review, we summarise the structure, function, channelopathies 
and pharmacological silhouette of the two-pore potassium channels in the human tissues. In 
addition, we present the computer model of the partially reconstructed wild type K2P1/TWIK1 
lacking the intracellular C and N terminal loops. Acta Biol Szeged 56(2):93-107 (2012)
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The structure of the two-pore domain channels 
The inward rectiÞer potassium channels (IKI) are responsible 
for the time course of the action potential (AP) (Dhamoon et 
al. 2005). IK1 and the background currents (IKb), both called 
leak currents, contribute to the resting membrane potential 
(Lesage et al. 2000a; Bayliss et al. 2008), and strongly inßu-
ence the Þnal repolarisation in cardiomyocytes, renal and 
neuronal cells (Prier et al. 1994; Nichols et al. 1997; Karle et 
al. 2002; Nerbonne et al. 2005; Millar et al. 2006; Bayliss et 
al. 2008). Furthermore, they also regulate diastolic membrane 
conductance (Dhamoon et al. 2004; Miake et al. 2003; Zobel 
et al. 2003) in the heart. During the time course of the AP, 
both IKI and IKb currents are active but their molecular basis 
is poorly understood in the heart and kidney, contrary to the 
brain. The strong inward rectiÞer current is determined by 
Kir2.x ion channels, while the IKb current is conducted by 
the two-pore ion channels (K2P) (Lesage et al. 1996a, 2000a; 
Goldstein et al. 2001; Gierten et al. 2008). Although, they are 
structurally very different (Nerbonne et al. 2001, 2005), both 
the Kir2.x and K2P channel subunits are thought to establish 
the structural and molecular basis of the IK1 ion channels in 
cardiomyocytes. The expression and properties of the above 
mentioned K+ channels are altered in cardiac diseases (ar-
rhythmias, Long QT syndromes, hypertrophic cardiomyo-
pathy, heart failure) or other, i.e. renal and neuronal diseases 
(Bayliss et al. 2008; Hedley et al. 2009; Gaborit et al. 2009; 
Greiser et al. 2009; Es-Salah-Lamoureux et al. 2010). 
K2P structure and their nomenclature
In the literature, the conventional name is frequently used 
instead of the systematic nomenclature accepted by the 
Human Genome Organization (HUGO; Goldstein et al. 
2005) for genes (KCNK1-18) and proteins (K2P1-18) of K2P 
channels. In this review, we mark both the latest and the old 
nomenclature.
Lesage et al. (1996a, b) have reported the structure of the 
Þrst member of the two-pore channel family, although it was 
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postulated much earlier. Their sequences are diverse; how-
ever, the K2P channels have two common structural features. 
First, the K2P channels possess two concatenated pore do-
mains on a single protein chain protomer (Fig. 1). Each pore 
domain of this tandem formation contains an outward and 
an inward membrane-spanning helix ßanking the potassium 
ion-selectivity Þlter segment and the concatenated membrane-
re-entrant pore helix (Lesage et al. 2000a; Nerbonne et al. 
2001, 2005). The other similarity is that the K2P channels hold 
a segment of about 60 amino acids on the extracellular surface 
inserted between the Þrst outward transmembrane helix and 
the Þrst pore domain (Fig. 1a). The role of this Òextracellular 
loopÓ in the channel function has not been revealed yet. The 
crystal structure of the human K2P channels has remained less 
well characterized compared to other potassium channels 
until now. Recently the structures of the TWIK1/K2P1 and 
TRAAK1/K2P4 channels were determined by Miller et al. 
(2012) and by Brohawn et al. (2012), respectively. 
The proteins with two P-loop domains, named as K2P1.1/
TWIK1, were cloned from human kidney (Lesage et al. 
1996a) and further analysis gave evidence for the existence 
of the four transmembrane domains (TM1-4). Following this 
recognition, 15 different K2P channels were identiÞed with 
two P-loop domains and four TM domains. They have been 
classiÞed into six subfamilies on the basis of sequence and 
functional similarity (TWIK, TREK, TASK, TALK, THIK 
and TRESK; see Table 1) (Prier et al. 1994; Lesage et al. 
2000a, b; Nerbonne et al. 2001, 2005; Bayliss et al. 2008; 
Enyedi et al. 2010). Based on the protein sequence a struc-
tural model showed that all subunits for the K2P channels are 
assembled as a dimer to form principally homodimeric or 
heterodimeric ion channels as it was presented by Berg et 
al. (2004) with one exception between K2P3.1/TASK1 and 
K2P9.1/TASK3 (Berg et al. 2004; Czirjak et al. 2002). Three 
of the 15 K2P channels have yet unknown physiological func-
tion yet because their current cannot be measured (K2P7.1/
KCNK7; K2P12.1/THIK2; K2P15.1/TASK5). Different animal 
species express diverse types of the physiologically active 
K2P channels with the 4TM/2P structure, such as ORK1 in 
Drosophila sp. (Goldstein et al. 1996), and more than 40 types 
in Caenorhabditis sp. and in plants.
Binding partners of K2P channels
The membrane potential is essential to the cardiac and neu-
ronal activity; therefore, the ÒleakÓ current regulation is an 
essential dynamical mechanism to control the cellular excit-
ability (Bayliss et al. 2003, Patel et al. 2001, Goldstein et al. 
2001). The trafÞcking by the different two-pore channels, 
their post-translational modiÞcation and localization in the 
membrane are different (Table 2). The auxiliary subunits 
bound to the pore-forming A-subunits of K2P channels were 
summarised by Plant et al. (2005) and Mathie et al. (2010) 
as shown in Table 2. Among those binding partners, SUMO 
(small ubiquitin-related modiÞer protein), 14-3-3 (HIV en-
coded partner) and Vpu1 (Viral protein U 1) have direct in-
teractions with K2P channels and the investigation of K2P have 
revealed new regulatory pathways (Czirjak et al. 2008). The 
14-3-3 proteins are members of the adaptor family proteins 
and they play a role in many cellular processes including 
apoptosis, metabolism, and membrane protein trafÞcking 
(Mrowiec et al. 2006). Furthermore, the 14-3-3 proteins were 
shown to be important in the intracellular trafÞcking and the 
promotion of forward trafÞcking between the ER and the 
plasma membrane.
The associated partners are modulators together with 
strong controlling external chemical and physical stimuli 
Figure 1. Schematic illustration of two-pore domain channels. Two pore-forming A-subunits associate as a dimer (right). TM1-4, transmembrane 
domain 1-4; P1, Pore-loop 1; P2, Pore-loop 2.
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including oxygen tension, pH, lipids, mechanical stretch, 
neurotransmitters and G-protein coupled receptors (Goldstein 
et al. 2002; Lesage et al. 2000b). SUMO silences K2P1 plasma 
membrane channels, phosphorylation of K2P3 enables 14-3-3 
binding to affect forward trafÞcking, whereas it decreases the 
open probability of K2P2; and, Vpu1, an HIV encoded partner, 
mediates an assembly-dependent degradation of K2P3. NOX4 
confers O2 sensitivity to channel K2P3.1/TASK1.
The TWIK1 associated protein partners are SUMO and 
ADP-ribosylation factor 6/exchange factor for ADP-ribosy-
Table1. mRNA expression and special function of two-pore channels in the human tissues. (reviews by: Lesage et al. 1996a,b, 
2000a,b; Lazdunsky et al. 2000; Bayliss et al. 2008; Enyedi et al. 2010).
Gene Acc.No. Protein Expression Function References
KCNK1 NM_002245               TWIK-1/
K2P1.1
brain, heart, kidney, liver, lung, 
ovary, pancreas, placenta, pros-
tate,  intestine, testis, colon
week inward rectifier;  cell 
volume regulation; in K+ 
secretion; may inhibits growth 
of tumor cells; deafness-asso-
ciated sensitization 
Lazdunsky et al. 2000  
Millar et al. 2006 
Gaborit et al. 2007
 
KCNK6 NM_004823                  TWIK-2/
K2P6.1
heart, kidney, liver, lung, ovary, 
pancreas, placenta, prostate, 
intestine, spleen, thymus
week inward rectifier; in K+ 
secretion;   
Millar et al. 2006
KCNK7 NM_033347 v. A  
NM_033348 v. B
NM_005714 v. C
NM_033455 v. D
BC004367                                   
KCNK7/
K2P7.1
brain, heart, kidney, liver, lung, 
ovary, pancreas, placenta, pros-
tate, skeletal muscle, intestine, 
spleen
functional currents not known 
var. A:longest transcript, B: 
shortest
C: the least abundant
Goldstein et al. 2001
KCNK2 AF129399 v1
NM_014217 v2 
NM_001017425 v3
                               
TREK-1/
K2P2.1
brain, heart, kidney, ovary, pros-
tate, skeletal muscle, intestine, 
testis
temperature and mechanical 
pain sensation; neuroprotec-
tion by PUFA; nociception; 
cardioprotection.
Lazdunsky et al. 2000
Cohen et al. 2008, 2009b
KCNK10 NM_021161 v. 1 
NM_138317 v.2 
NM_138318  v.3                    
TREK-2/
K2P10.1
brain, kidney, heart mechanical stretching Kim et al. 2000a
Lesage et al. 2000a,b
Kazanski et al. 2010 
KCNK4 AF247042                TRAAK/
K2P4.1
brain, kidney, placenta, prostate, 
intestine, testis
modulated by PUFA and 
temperature
Kim et al. 2000b
Kang et al. 2005
KCNK3 NM_001017424v.1 
NM_014217  v.2
NM_002246  v.3                  
TASK-1/
K2P3.1
brain, heart, kidney, liver, lung, 
pancreas, placenta, prostate, 
intestine
sensitive to changes in extra-
cellular  acidic pH 
Cohen et al. 2008
KCNK5 NM_003740               TASK-2/
K2P5.1
heart, kidney, liver, lung, pan-
creas, placenta, ovary 
renal acidosis; regulation of 
respiration; osmotic vol-
ume regulation; sensitive 
to changes in extracellular 
alkaline pH
Gestreau et al. 2010
Olschewski et al. 2008
Hoste et al. 2007
KCNK9 NM_016601
NG_012842                            
TASK-3/
K2P9.1
brain, heart, kidney, liver, lung sensitive to changes in 
extracellular alkaline 
pH;characteristic dismorphism 
Cohen et al. 2008, 2009b
KCNK16 NM_001135105v.1
NM_032115 v2
NM_001135106v.3
NM_001135107v.4          
TALK-1/
K2P16.1
brain, heart, kidney, liver contribute to bicarbonate 
reabsorbtion; control of 
apoptotic volume of kidney 
proximal cells
Cho et al. 2012
Duprat et al. 2005
KCNK17 NM_031460  v.1  
NM_001135111v.2
                    
TALK-2/
K2P17.1
exocrine pancreas, heart role in the ischemic stroke Domingues-Montanaria et 
al. 2010 
Girard et al. 2001
KCNK15 NM_022358               TASK-5/
K2P15.1
olfactory bulb mitral cells, cer-
ebellar Purkinje cells
sensitive to changes in extra-
cellular alkaline pH,
functional currents not known 
Marsh et al. 2012
KCNK13 NM_022054               THIK-1/
K2P13.1
in the proximal and distal neph-
ron of kidney
stimulated by arachidonic acid Rajan et al. 2001
Theiliget al.  2008
Morrison et al. 2010
KCNK12 NM_022055 
NG_007110                         
THIK-2/
K2P12.1
kidney, brain, heart functional currents not known Nyholt et al. 2008
Theilig et al.2008
KCNK18 NG_028085              TRESK/
K2P18.1
brain temperature detection; noci-
ception;  migraine and related 
disorders; immunmodulators
King et al. 2004
Lafrenière et al. 2011
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lation factor 6 (ARF6/EF6). SUMO silences the K2P1 plasma 
membrane channels (Plant et al. 2005; Rajan et al. 2005). 
SUMO and ARF6 bind to the K2P1/TWIK1 channel. K2P1 
is silent when it bounds SUMO and active when SUMO is 
absent (DÕSouza-Schorey et al. 1995).
TASK channels interacting with 14-3-3 are present at the 
plasma membrane (Rajan et al. 2002). It was shown that the 
seven isoforms of 14-3-3 associate to the TASK channels, 
however OÕKelly et al. (2002, 2008) demonstrated that 14-
3-3B binds with the highest afÞnity. 
Molecular model of the human K2P1.1/TWIK1 
channels
After several years of pharmacological investigations of the 
K2P channels, Þnally the molecular structure of the human 
K2P1.1/TWIK1 was revealed by Miller et al. (2012 with a 
comment) presenting the 3.4 Angstrom resolution crystal 
structure of the human K2P1/ TWIK1 channel. (See in Fig. 2 
and Supplemental Þgures of TWIK1, Chatelain et al. 2012). 
The mechanosensitive TREK and TRAAK channels are able 
to form an amphipathic A-helix that is different from other 
2P channels. Recently, Milac et al. (2011) have built a model 
of TREK channels forming a parallel dimeric coiled-coil in 
closed and open conformations. Brohawn et al. (2012) also 
presented the crystal structure of the human K2P4/TRAAK 
channel at a resolution of 3.8 Angstrom.
Our 3D structure of TWIK-1 was built by homology mod-
elling based on the experimental structure (Miller et al. 2012). 
It was necessary to reconstruct the wild type sequence be-
cause the experimental structure is lacking of two fragments 
(residues 94-99 and 169-174) and contains mutated residues 
replaced for Cys22 and Asn95 (Fig. 2). A relaxed structure 
was obtained by energy minimization and the arrangement 
of the side chains in the critical pore domain was found to be 
identical with that of the experimental structure.
Discussion
The two pore loops and helices are different within one 
chain. One important difference may be the presence of Leu 
in pore 2 (Fig. 3B pore 2) in place of Tyr located in the same 
position in pore 1 (Fig. 3A pore 1). It is stated by the experi-
ments with engineered 2P channels that this Tyr is essential 
Table 2. Associated proteins involved in the regulation and modulation of two-pore channels. Acronyms: ADP-ribosylation Factor 6, 
ARF6; A-kinase anchoring protein 150, AKAP150; protein kinase A, PKA; Coatomer protein complex 1 COPI; Endoplasmic reticulum, 
ER; Exchange Factor for ADP-ribosylation factor 6, EF6; microtubule-associated protein,  Mtap2; protein kinase C, PKC; HIV encoded 
partner, 14-3-3;  NADPH oxidase 4, NOX4; Viral protein U 1, Pvu1; Polyunsaturated fatty acid, PUFA; Small Ubiquitin-related Modifier 
Protein, SUMO; Tyrosine kinase, TK.
Gene Protein Binding 
partners
Presumed role References
KCNK1 TWIK1/
K2P1.1
SUMO 
ARF6/EF6
‘Silences’ the channel: controls open probability
by reversible linkage to K2P1
Enhances channel internalization
Rajan et al.2005 Mathie et al. 2010
KCNK6 TWIK2/
K2P6.1
TK TK inhibition reduces beneficial effects on cardiac ischaemic pre-
conditioning and cardioprotection
Gierten et al. 2008
Cho et al. 2005
Gierten et al. 2008
KCNK3 TASK1/
K2P3.1
14-3-3
COPI
TK, PKA
Pvu1
NOX4
Increases the surface expression of the channel
Channel is retained in the ER
TK-related block may cause prolonged  repolarization and, per-
haps, dysregulation of cardiac pacemaker activity
Assembly-dependent degradation, diminishes channel number by 
increasing the degradation 
Confers O2 sensitivity on channel
Rajan et al. 2002
Zuzarte et al. 2009
Mathie et al. 2010
O’Kelly et al. 2002
Gierten et al. 2008
KCNK5 TASK2/
K2P5.1
14-3-3 Increases the surface expression of the channel Rajan et al. 2002
KCNK9 TASK3/
K2P9.1
14-3-3
COPI
TK
Regulates channel number by controlling the forward transport to 
the plasma membrane
Channel is retained in the ER
Effects on cardiac ischaemic preconditioning and cardioprotection
Zuzarte et al. 2009
Mathie et al. 2010
O’Kelly et al. 2002
Gierten et al. 2008
KCNK2 TREK1/
K2P2.1
Mtap2
14-3-3
AKAP150
PKC
Enhances surface expression and current density
Increased current by binding to regulatory domain
PKC-mediated phosphorylation decreases the open probability 
Rajan et al. 2002
Sandoz et al. 2006 Sandoz et al. 
2008
Plant et al.2005
KCNK13 THIK-1/
K2P13.1
TK Effects on cardiac ischaemic preconditioning and cardioprotection Gierten et al. 2008
KCNK18 TRESK/
K2P18.1
14-3-3
calcineurin
Regulates calcineurin-mediated activation of the channel Czirjak et al. 2008
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for the selectivity toward potassium (Chapman et al. 2001). 
The bulkier side chain of Tyr with hydrogen bonding capac-
ity may rigidify the pore, compared to Leu. Another major 
difference is the presence of His in pore 1 (Fig. 3A) in place 
of an Asp in the same position of pore 2 (Fig. 3B). This Asp 
can be found in many homotetrameric potassium channels 
too, and it is stated to be responsible for the stability of the 
open state of the channel (Chapman et al. 2001). Altogether, 
the GYGD motif in the pore loop of a potassium channel is 
essential resulting in a selectivity ratio of ca. 1000 between 
K+ and Na+. In TWIK1, none of the pore loops possesses 
this motif, which may be the reason that in the case of lower 
physiological concentration of extracellular potassium the 
channel starts to transport sodium leading to Þbrillation and 
arrhythmia (Ma et al. 2011). Further differences can be found 
between P1 and P2. In identical position of the pore helices 
there are a Phe and a Tyr in P1 and P2, respectively, with 
obviously different H-bonding capacities. There is a Glu at 
the N-terminal end of P2 not being present in P1. Aa Glu in 
a similar position can also be found in many potassium chan-
nels, facing to the above-mentioned Asp.
Expression and function of two-pore domains 
channels 
Genomic and functional studies pointed to an important role 
of various K2P channels in brain, kidney and heart diseases, 
but so far, only poor and contradictory molecular data have 
been described. At the past decades, numerous channels were 
investigated in different ways, including DNA sequencing, 
microarray analysis, immunocytochemistry and breeding 
transgenic animals differently expressing various types of K2P 
channel proteins compared to wild type undiseased animals. 
These channels are essential in numerous physiological pro-
Figure 2. The dimer of the wild type channel. The reconstituted residues 
of the chains are shown in yellow and the cistin bridge by atom type 
(C in green, O in red, N in blue).
Figure 3. The specific residues in selectivity filter 1 and in pore helix 1 (A) and in selectivity filter 2 and in pore helix 2 (B). Residues in the selec-
tivity filters are coloured by atom type (C in green, O in red, N in blue), the differing Tyr and Phe in the pore helices shown in yellow.
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cesses, and recently have been shown to participate in human 
pathologies as well. These channels were also overexpressed 
in various human kidney, melanoma, brain and heart cell lines 
and tissues.
K2P channels conduct potassium-selective ÒleakÓ currents 
that are time- and voltage- independent, playing pivotal role to 
set and control the resting membrane potential, the potassium 
homeostasis and the volume of the cells. Furthermore, they 
modulate various physiological functions related to altered 
membrane potential, i.e. neurotransmitter and hormone secre-
tion, as well as neuronal and muscular excitability (Lesage 
et al. 2000a; Kim D 2005; Bayliss et al. 2008; Cohen et al. 
2009b; Enyedi et al. 2010). Gurney et al. (2009) recently 
published a review of two-pore potassium channels in the 
cardiovascular system. 
The Þrst cloned K2P1.1/TWIK1 channel is widely ex-
pressed at the transcriptional as well as the translational level 
in the brain, heart, kidney, lung, ovary, pancreas, placenta, 
prostate, testis, intestinal smooth muscle, and colon (Lesage et 
al. 1996a). Regional expression of K2P1.1/TWIK1 in the heart 
was highly expressed at both mRNA and protein level in the 
right and left atria as well as in Purkinje Þbers and in about a 
30% lesser extent in the right and left ventricle (Gaborit et al. 
2007). We detected K2P1.1/TWIK1 by immunoßuorescence in 
the intercalated discs of the left ventricle (Fig. 4a). Confocal 
microscopy studies showed that both TWIK1 and TASK1 
were expressed in the intercalated discs in the ventricle (Fig. 
4A, 4B). K2P3.1/TASK1 mRNA expression is one magnitude 
Figure 4. The protein expression of two-pore domain ion channels in the human left ventricle of the heart. (A) K2P1.1/TWIK-1 immunolocalized 
in the intercalated discs of the left ventricle. (B) K2P3.1/TASK1 proteins expressed in the intercalated discs and the lateral side of sarcolemma.
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less expressed in the ventricle. 
Recently we showed gender differences of several Kv 
ion channels from donor hearts (Gaborit et al. 2010). Its 
importance is raised because K+ channels are known to be 
important determinants of the human arrhythmic risk involv-
ing K2P channels. However, our study revealed that there are 
no gender differences in the expression of either the most 
abundant K2P1.1/TWIK1 or the K2P5.1/TASK2 channels. In 
contrast, the transcripts for K2P3.1/TASK1 were 3-fold more 
abundant in female left ventricle (LV) endocardium and 
epicardium (Gaborit et al. 2010) which might be consider-
ably different in normal physiology conditions in contrast to 
diseased states.
 K2P1.1/TWIK1 and K2P6.1/TWIK2 ion channels are 
known as weak inward rectiÞers. K2P2.1/TREK1 and K2P4.1/
TRAAK are polyunsaturated fatty acid (PUFA) and stretch-
activated K2P channels whereas K2P3.1/TASK1 and K2P5.1/
TASK2 are acid-sensitive channels. K2P2.1/TREK-1 is the 
only known outward rectiÞer channel. However, KCNK6 and 
KCNK7 are possibly silent genes.
K2P1.1/TWIK1 channels are expressed in the heart (Wang 
et al. 1998), cerebellum, thalamus (Talley et al. 2001), and 
kidney (Levy et al. 2004). Under in vitro conditions, K2P1.1/
TWIK1 was detected mainly in recycling endosomes (RE) 
in native and transfected cells. K2P1.1/TWIK1 gene inactiva-
tion leads to the loss of nonselective cationic conductance, an 
unexpected effect that was attributed to the adaptive regula-
tion of other channels (Millar et al. 2006) in renal principal 
cells. 
It was reported that TWIK1 is responsible for the para-
doxical depolarization of the human heart during patho-
logical hypokalemia (Ma et al. 2011). The ion selectivity of 
TWIK1 is highly modulated by the extracellular pH. Although 
TWIK1 is K+ selective at neutral pH, it becomes permeable 
to Na+ at the acidic pH found in endosomes (Chatelain et al. 
2012). At acidic pH, typical in the secretory and endocytic/
recycling pathways, TWIK1 conducts Na+ behaving as a 
nonselective cationic channel in RE. The transitions from 
the Na+-conductive state to the K+-selective state are very 
slow, suggesting that TWIK1 delivered to the cell surface 
will remain nonselective for several minutes at the plasma 
membrane. This phenomenon could explain the loss of cat-
ionic conductance and the hyperpolarisation of the resting 
membrane potential recorded in TWIK1/ knock out kidney 
cells. It was also shown that TWIK1/ pancreatic B cells are 
hyperpolarized compared with the control wild type cells, 
particularly when the ATP-sensitive K+ channels are turned 
off by the presence of glucose in the medium endosomes 
(Chatelain et al. 2012). 
TASK (TWIK-related Acid-Sensitive K channels channel 
family) was one of the Þrst K2P channels discovered, and it 
was intensively studied being it was essential in anaesthesia 
and in the therapy of brain diseases. Regional expression 
of TASK1, TASK3, and TASK5 was reported in the brain 
(Karschin et al. 2001). They were also detected in the heart 
(Fig. 4A, 4B), kidney, liver, lung, pancreas, placenta, and 
ovary. In the right and left atria, the mRNA expression for 
TASK1 was abundant, but one order of magnitude less nucleic 
acid was detected in the Purkinje Þbre and the ventricle of 
the heart (Gaborit et al. 2007). TASK2 was also expressed 
with the same ratio as TASK1 in different regions of the heart 
but much lower amount was detected compared with TASK1 
or to TWIK1. We detected TASK1 in the intercalated discs 
similarly to TWIK1 in the ventricle (Fig. 4A, B).
All types of K2P A-subunits are expressed in the human 
kidney, TWIK1 and TASK2 are the most abundant, similarly 
to the heart (Table1). TWIK1 was immunolocalized in the 
rat kidney, where it is highly expressed in the brush-border 
membrane of the proximal convoluted tubules, in the thick 
ascending limb of the loop of Henle, and in the collecting duct 
intercalated cells, both by intracellular and apical localization 
(Cluzeaud et al. 1998). 
Similarly to the kidney, all K2P subunits are expressed 
in the brain and mostly different K2P channels are mapped. 
TWIK1 is abundant in the human brain and plays essential 
roles in diverse physiological functions in neuronal cells 
(Bayliss et al. 2008; Enyedi et al. 2010). 
K2P2.1/TREK1 is expressed in rat left and right atria, ven-
tricles and septum (Terrenoire et al. 2001; Tan et al. 2004) but 
not reported in the human myocardium. TREK1 is located in 
the longitudinal stripes at the surface of cardiomyocytes that 
conforms to the sensing of longitudinal stretch in myocytes 
(Li et al. 2006). However, there is no evidence for colocaliza-
tion with membrane-associated cytoskeletal proteins in the 
ÒcostamersÓ (Kostin et al. 1998).
K2P2.1/TREK1 channel exhibits two distinct types of 
current, the large and small conductance states, at positive 
potential in rat cardiomyocytes (Li et al. 2006). It exists in two 
distinct splice variants, TREK1a and TREK1b in the myo-
cytes. It highlights the importance of the post-translational 
regulation of TREK1 that might affect the conductance of 
this channel and it is supposed that TREK1 may be involved 
in balancing the membrane potential and the duration of the 
action potential as an outward rectifying current (Terrenoire 
et al. 2001; Li et al. 2006). 
TREK1, TREK2, K2P2/K2P10 (TWIK-Related K channels) 
and TRAAK (TWIK-Related Arachidonic Acid (AA)-stim-
ulated K channel) channels have diverse electrophysiologi-
cal properties (Kim et al. 2001a, b; Lesage et al. 2000a, b). 
K2P2.1/TREK1 is a mechanogating stretch-activated channel, 
which is also activated by PUFAs, phospholipids, volatile 
anaesthetics, intracellular acidiÞcation (decreased pHi) and 
increased temperature. They are inhibited by GAs- and GAq-
linked GPCRs through protein kinase A (PKA) and PKC 
pathways, respectively, and activated by a PKG-mediated 
mechanism. TREK-1 is reciprocally sensitive to extracel-
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lular Mg2+ changes than are the TREK-2 and TRAAK chan-
nels (Kim et al. 2001a, b). Regulation of K2P channels by G 
protein-coupled receptors was also investigated in neuronal 
tissues (Mathie A 2007).
TREK1 is abundantly expressed in smooth muscle and 
the endothelial layer of the basilar artery, and is essential in 
the modulation of the cerebrovascular tone. 
The studies of the mechanically gated channels, TREK1/
K2P2.1), TREK2/K2P10.1), and TRPC6 (Transient Receptor 
Potential Cation channel 6) channels study showed (Ka-
zanski et al. 2010), that NO plays a role in the regulation of 
the activity of these channels. Furthermore, the endothelial 
NO-synthase predominates as NO source in cardiomyocyte 
response to stretching.
K2P13.1/THIK1 and K2P12.1/THIK2 are arachidonic acid 
sensitive K2P channels, and they are expressed in the kidney, 
brain and in the vasculature. The mRNA for K2P13.1/THIK1 
but not that of K2P12.1/THIK2 was detected in the heart 
(Kim et al. 1998). In the vasculature the arachidonic acid 
sensitive K2P channels are localized in the arteries and play 
an important role (Gurney et al. 2009) in the endothelial cells 
in the regulation of the vascular tone (Blondeau et al. 2007; 
Garry et al. 2007). The rat mesenteric and femoral arteries 
express TREK1, TREK2 and THIK. TRAAK is detected in 
mesenteric artery but not in femoral artery (Gardener et al. 
2004; Goonetilleke et al. 2007). 
K2P4.1/TRAAK (TWIK-related arachidonic acid-stimulat-
ed potassium channel protein) is a lipid- and mechanosensi-
tive K+ channel in K2P family. This protein forms homodim-
ers and functions as an outwardly rectifying channel. It is 
expressed principally in neural tissues and stimulated by 
membrane stretch and polyunsaturated fatty acids. Proteins in 
TREK family (TREK1, TREK2 and TRAAK) are inactivated 
by hypo-osmolarity and phosphorylation by protein kinase A 
and C (Lesage et al. 2003). 
K2P16.1/TALK1 and K2P17.1/TALK2 are expressed in 
the exocrine pancrease, and also in the heart (Girard et al. 
2001) and sensitive to external alkalic pH such as TASK1 and 
TASK2 (Duprat et al. 2005). However, TASKs are expressed 
in the islets of Langerhans. Nitric oxide (NO) speciÞcally 
activates TALK1 and TALK 2, and they are might be under 
NO dependent stimulation (NOS). Interestingly, the current, 
generated by TALK2 channel, is low at physiological pH 
and NOS is mostly active on TALK2 suggesting that the 
NOS plays a role in the preconditioning as well (Duprat et 
al. 2005).
Physiological effects on the K2P domain channels 
and their pharmacological targeting 
Physiology and pharmacology of K2P channels are intensively 
studied in the past decades mainly in the central nervous 
system (Kim 2005; Duprat et al. 2007; Cohen et al. 2009a, 
b; Enyedi et al. 2010), however, the role of these channels 
in the cardiovascular system is still to be explored. Here we 
also present evidence focusing on the latest yearsÕ results 
from pharmacological and regulatory aspects in the cardio-
vascular system. 
Physiological roles and pharmacological 
properties 
The non voltage-gated K2P potassium channels, TASK1, 
TASK3, and TREK1 contribute to anaesthetic-induced hypno-
sis and immobilization. Buckler et al. investigated TASK-like 
channels in rat arterial chemoreceptor cells studying oxygen-, 
acid-, and anaesthetic-sensitivity. Duprat et al. (2007) have 
shown that TASK channels function as chemo-, and nutri-
ent sensors. However, TASK channels are not required for 
brainstem control of breathing by CO2 or pH despite wide 
expression in these areas. TASK channels are necessary for 
adrenal aldosterone secretion. TREK-1 channels contribute to 
temperature and mechanical pain sensation, neuroprotection 
by PUFAs, and mood regulation. TASK2 channel is necessary 
for HCO3- reabsorption and osmotic regulation in the kidney 
proximal tubules (Bayliss et al. 2008).
Experiments with transgenic mice presented evidence that 
TREK channels mediate the effect of PUFA during an isch-
emic attack, not only by hyperpolarizing neurons (and thus 
reducing the susceptibility to ischemia), but also enhancing 
the circulation in/or nearby the affected region (Blondeau et 
al. 2007; Enyedi et al. 2010).
The expression and the pharmacological properties of 
TASK-1 were investigated in human pulmonary artery smooth 
muscle cells (Olschewski et al. 2006) resulting in an evidence 
that moderate hypoxia is a blocker of TASK1. However, 
treprostinil activates this channel mediated by PKA, which 
may indicate the pivotal mechanism underlying the vasorelax-
ing properties of prostanoids. 
Localization of pain is important in all organs /tissues 
but understanding the molecular mechanism of nociception 
has just started only a few years ago, and it is still far from 
elucidation. CohenÕs group highlighted the importance of 
K2P2.1/TREK1 channels in the process of sensitization of pain 
signalling and its modulation (Cohen et al. 2008, 2009b). 
K2P18/TRESK (TWIK-related spinal cord K+ channel, 
KCNK18) channels are mainly expressed in the dorsal root 
ganglion (DRG) neurons and they have been suggested to 
play a key role in pain disorders (Kang et al. 2004; Dobler 
et al. 2007; Huang et al. 2008; Mathie A 2010; Tulleuda et 
al. 2011). Examining the TRESK channel Liu et al. (2004) 
highlighted the possibility of activation of the human K2P2 
channels by clinical concentrations of volatile anaesthetics. 
Furthermore, the dominant-negative mutation of TRESK1 
channel was reported to be linked to familial migraine with 
aura (Lafreniere et al. 2010; Braun et al. 2011). Studying 
TRESK channels in the heart requires concerted efforts of 
multiple research laboratories. 
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K2P channels are relatively insensitive to classical K+ chan-
nel blockers such as TEA, Ba2+, and Cs+. TASK1 channels 
are selectively inhibited by the endocannabinoid anandamide. 
TREK1 is a stretch-activated and heat sensitive channel. 
TREK1, TREK2, TRAAK and THIK1 are stimulated by 
arachidonic acid and PUFAs. K2P channels are generally 
sensitive to inhalation and local anaesthetics, but TWIK2 
and TRAAK channels show no sensitivity to anaesthetics 
(OÕConnell et al. 2002). Several laboratories reported that 
inhalational anaesthetics activate K2P channels, hyperpolariz-
ing neurons in the mammalian central nervous system (Nicoll 
et al. 1982; Patel et al. 1999; Buckler et al. 2000). Different 
effects of volatile anaesthetics on human TASK-1 channels 
expressed in Xenopus oocytes are found. They are insensi-
tive to propofol but inhibited by etomidate and stimulated by 
sevoßurane and isoßurane (Putzke et al. 2007a, b).
Pharmacological effects on cardiac K2P channels
Slowing of the intrinsic heart rate may be explained by the 
increased expression of TASK1, TWIK1, TWIK2, K(ir)2.4 
channels, calsequestrin 2, and the A1 adenosine receptor in 
the sinoatrial node (SAN) in the heart (Yanni et al. 2011). 
Alterations in the gene expression of the ion channels have 
also occurred in the sinoatrial node dysfunction induced by 
heart failure. 
The endocardial and epicardial differences and the re-
gional differences in the stretch activation of ventricle (Tan 
et al. 2004) are possibly caused by TREK1. This leads to 
the differential mechano-electrical feedback and reduces the 
action potential repolarization in areas of the myocardium 
where the conduction velocity is lower (Lab 1999; Ravens 
2003; Gurney et al. 2009). 
The antidepressant ßuoxetine inhibits cardiac and cerebral 
TREK1 channels expressed in HEK-293 cells and Xenopus 
oocytes. Sensitivity was decreased by 70% when Þrst 52 
amino acids were removed (Eckert et al. 2011). 
The class III antiarrhythmic drug amiodarone prolongs the 
action potential and suppresses arrhythmia in human TASK1 
channels expressed in Xenopus oocytes (Gierten et al. 2010). 
TASK1 channels in rat cardiac myocites substantially contrib-
ute to outward potassium current during plateau phase and 
this current can be inhibited by the A1A adrenergic agonist 
methoxamine. A293 was a selective blocker of TASK1 chan-
nel expressed in Xenopus oocytes (Putzke et al. 2007a, b).
K2P channel related regulation, trafficking 
and diseases with treatments
Molecular mechanism of the regulations of two-
pore domain channels 
K2P channels exhibit different pharmacological effects and 
there are diverse regulatory and signalling pathways behind 
this. In the myocytes, contraction is stimulated by the rise in 
the Ca2+ concentration of the cytosol in myocytes where an 
increased Ca2+ concentration is the endpoint of many differ-
ent pathways. Small proteins or carbohydrates are frequently 
attached to K2P channels to modulate their physiological 
effects. The mechanism of the trafÞcking, post-translational 
modiÞcation, and localization in the membrane are different 
for the two-pore channels. The auxiliary subunits binding to 
the pore-forming A-subunits of the K2P channels were sum-
marised (see in Table 2; Plant et al. 2005; Mathie et al. 2010). 
K2P channels can be activated by different stimuli such as cell 
membrane stretch, lysophospholipids and arachidonic acids, 
and inactivated or modulated by physicochemical factors, 
endogenous neurochemicals and clinically relevant drugs 
(Bayliss et al. 2008; Gurney et al. 2009).
TWIK1 regulation is strongly effected by the ADP-ribo-
sylation factor 6 (ARF6). The small protein, ARF6 which is 
a part of the RAS superfamily, was recently cloned (acc.no. 
NM_001663.3, the translated protein id. is NP_001654.1. 
It is abundantly expressed in the heart, widely present in 
other tissues (Tsuchiya et al. 1991) and functionally and 
physically associated with the Golgi complex (Stearns et al. 
1990; Deutsch C. 2003). A sequence homology of 100% was 
identiÞed in vertebrates and high homology was found even 
with Saccharomyces pombe. This factor is a member of the 
human ARF gene family, and the ARF gene encodes the small 
guanine nucleotide-binding protein (175aa) that stimulates 
the ADP-ribosyltransferase activity of cholera toxin (Welsh 
et al. 1994). ARF6 plays a role in the vesicular trafÞcking and 
acts as an activator of phospholipase D (DÕSouza-Schorey et 
al. 1995). It is localized in the plasma membrane, and regu-
lates the vesicular trafÞcking via remodelling the membrane 
lipids and signalling pathways that most probably lead to 
actin remodelling. A pseudogene of this gene is located on 
chromosome 7 under the A-adrenerg regulation. 
In the heart, Doroudgar et al. (2009) investigated the stress 
response of the endoplasmic reticulum under ischemic condi-
tions where the ATF6 branch has been activated. Possibly the 
Toll-like receptor 9-mediated signalling plays a role in this 
mechanism (Wu et al. 2012).
K2P3/TASK1, TASK3, and the non-functional TASK5 
associate to 14-3-3 proteins in recombinant and native form 
(Girard et al. 2002). When COP1 interacts with TASK chan-
nels, the surface expression of these channels as well as the 
accumulation of the channels are decreased in the ER. Thus 
14-3-3 and COPI act in opposite ways either enhancing the 
TASK channelsÕ forward trafÞcking towards the membrane 
or retaining the TASK channels in the ER, respectively. 
Modulation of TASK channels by protein kinase C has also 
been investigated (Gierten et al. 2010).
Recently it was shown that the TASK1 channel protein 
interacts directly with NADPH oxidase 4 (NOX4) (Park et 
al. 2009) to confer oxygen sensitivity to TASK1 and medi-
ate the oxygen-sensitive K+ current response in carotid and 
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neuro-epithelial bodies (Lee et al. 2006; Duprat et al. 2007). 
Recently, it has been evidenced that TASK1 is neuroprotective 
under ischemic conditions (Meuth et al. 2009).
TREK-1 channels are activated by PUFAs, phospholipids, 
stretch, volatile anesthetics, intracellular acidiÞcation (de-
creased pHi) and by elevated temperature. They are inhibited 
by GAs- and GAq-linked GPCRs through protein kinase A 
(PKA) and PKC, but activated by a PKG-mediated mecha-
nism (Patel et al. 1995; Honore et al. 2007). 
Mathie et al. (2010) examined the TASK channel traf-
Þcking from the endoplasmic reticulum (ER) to the plasma 
membrane via the Golgi apparatus and then focused on the 
established regulatory mechanisms for K2P channel trafÞck-
ing. Localisation of TREK channels to particular regions of 
the neuronal membrane and the involvement of binding part-
ners such as A-kinase anchoring protein 150 (AKAP150) and 
microtubule-associated protein (Mtap2) in this localisation 
was reviewed. The binding partners regulating the localisa-
tion of TWIK1 are ARF6 together with EFA6, and Vpu for 
TASK1 Mathie et al. (2010).
Post-translational regulation of K2P channel trafÞcking 
controls the number of functional channels and has an effect 
on the functional properties in different cells (neurons, car-
diomyocytes, endothelial cells) (Mathie et al. 2010; Enyedi 
et al. 2010). It was reported that P11 might promote forward 
trafÞcing together with 14-3-3, which binds to the last three 
amino acids of the carboxy terminal for transferring the as-
sociated K2P complex to the plasma membrane. On the other 
hand, P11 is able to associate with TASK1 too in the presence 
of 14-3-3. 
Different agents via calcineurin-mediated pathway (Czir-
jk et al. 2004) can activate TRESK. The pivotal role of en-
dogenous calcineurin in TRESK activation has been veriÞed 
in mammalian cells (Czirjk et al. 2006). The regulation of 
TRESK by calcineurin is in good accordance with the pre-
vious result that TRESK and calcineurin are associated via 
direct protein-protein interaction (Kang et al. 2006, 2008). 
Mathie et al. (2007) showed that MARK directly phospho-
rylates TRESK in vitro and speciÞcally inhibits the TRESK1 
channels. Mutagenesis studies proved that the phosphoryla-
tion of Serine 264 and the direct interaction of 14-3-3 with 
TRESK were not indispensable for the effect of MARK2, 
suggesting that this kinase acts via the Ser274/Ser276/Ser279 
cluster (Braun et al. 2011). These results are connected with 
two presently emerging Þelds, the cellular polarity and the 
microtubule dynamics, and suggested that their control is 
coupled to the regulation of the background K+ current in the 
cells, which express TRESK.
Diseases refer to K2P channels with treatments
Cases of K2P diseases with inherited or aquired mutations have 
only been detected in neuronal diseases. We have data for 
altered transcripts or protein levels of K2P channels in a few 
diseases. Recently mutations and related channelopathies of 
K2P have been discovered, as well as the regulation by small 
proteins associated to A-subunits of K2P concerning brain or 
kidney diseases.
The dominant-negative mutation of TRESK1 channel was 
discovered to be related to familial migraine with aura Lafre-
niere et al. 2010; Braun et al. 2011). TRESK2 and THIK2 
were shown also the cause of migraine (Nyholt et al. 2008).
KCNK1 and KCNK2 coding genes for TWIK1 and 
TASK1 were both down-regulated at transcriptional and 
translational levels in dilated cardiomyopathy (DCM; Szts 
et al. unpublished data) but we have no data if there were any 
mutations of K2P channels.
First, the neuronal background of K2P channels was fo-
cused on physiological studies targeting TASK channels and 
TREK1 for effective treatments in anaesthesia and neuronal 
diseases (Patel et al. 1999; Honore et al. 2007; Olschewski 
A 2010). 
In cardiac Brugada syndrome there is an inherited sudden-
death arrhythmia syndrome where the ion channels monitor-
ing exhibited distinct clustering differences versus the control 
non-diseased and other ventricular-tachyarrhythmia groups 
(Gaborit et al. 2010) among 14 of 77 genes encoding impor-
tant ion-channel/ion-transporter subunits. Among these K+-
channel genes, Brugada patients showed greater expression 
of the two-pore domain gene KCNK1/TWIK1 and reduced 
expression of Kv4.3 involved in the transient-outward K+-
current IBg and ITO, respectively. The latest might cause the 
susceptibility for arrhythmia. The interindividual variability 
appears to be homogenous throughout the Þve groups, except 
for TWIK1 and HCN3, which are more variable in Brugada 
patients than in other groups. In humans, the 2P-domain K+-
channels TWIK1 and TASK2 are more strongly expressed in 
Purkinje Þbres than in the right ventricle, with higher level 
of expression of TWIK1 than TASK2 (Gaborit et al. 2007). 
Preferential expression of a 2P-channel in Purkinje Þbres also 
occurs in mice. Increased 2P-channel expression might also 
compensate for reduced Na+-channel function.
The neuronal two-pore domain potassium-channels and 
their modulators have been proposed as potential drug targets 
and have importance in anaesthesia, neuronal diseases, pain, 
migraine, Alzheimer disease etc. Recently the TREK and 
TRESK ion channels were examined and highlighted as novel 
therapeutic targets in the treatment of pain (Mathie et al. 2007; 
Mathie A 2010). K2P channels in other organs, e.g. in the heart, 
should also be considered as potential targets.
 Nowadays, the cardiac arrhythmia is one of the most 
widespread diseases not only in the elderly, but in the middle 
and younger ages too. A great number of people suffer also 
from depression. K2P channels are targeted in current anti-
depressant (AD) treatments. One of the potential candidate 
drugs, spadin, blocks TREK1s, which are considered as new 
targets for AD but blocking these channels may result in del-
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eterious side effects. Moha et al. (2012) showed that spadin 
did not interfere with other TREK1 controlled functions such 
as pain, epilepsy and ischemia. Spadin was unable to inhibit 
currents generated by TREK2, TRAAK, TASK and TRESK 
and, spadin also did not induce cardiac dysfunctions.
In the treatment of cardiac arrhythmia, one of the selec-
tive targets is the K2P3.1 (TASK-1) potassium leak channel 
using amiodarone, a class III antiarrhythmic drug (Mathie 
et al. 2007; Gierten et al. 2010). Its therapeutic potential in 
neuronal anaesthesia was reported by Yoo et al. (2009) and 
in cardiology (Sear JW 2010). 
Nowadays, ion channels as novel therapeutic targets are of 
increasing importance in the treatment of pain and migraine 
targeting K2P2.1/TREK, K2P18.1/TRESK channels (Mathie et 
al. 2007; Mathie 2010).
For effective treatment in cardiac, renal and cerebral 
diseases we need to know the exact mechanism of the action 
of the drugs as well as their metabolic pathways and their 
possible side effects. Targeting the K2P channels may have a 
wide perspective in various diseases. Recognizing new effects 
on these channels by drugs already in use is also important. 
Further development can be expected from the application of 
agents targeting K2P channels, e.g. antiarrhythmic drugs, with 
new mechanism of action.
Conclusions
K2P channels conduct potassium-selective ýleaký currents, 
which are time- and voltage- independent, and play pivotal 
role setting the resting membrane potential and controlling 
the potassium homeostasis and the cell volume. Furthermore, 
they modulate various physiological functions related to 
altered membrane potential, an consequent i.e. muscular and 
neuronal excitability, as well as neurotransmitter and hormone 
secretion. These channels serve as the molecular targets for 
certain volatile and local anaesthetics yet. We have to improve 
our knowledge in order to understand the exact mechanisms 
and regulations by binding partners of K2P channels in the 
heart. That could considerably speed up the development of 
future therapies directed towards local regions of the heart 
in cardiac diseases. 
Materials and Methods
Homology modelling 
Homology modelling was performed by the program pack-
age MODELLER 9v8) ( ali et al. 1993) running under Linux 
Kubuntu (http://www.kubuntu.org) 11.4, Mandriva 2011 
(http://www.mandriva.com/eu/linux). The model building 
algorithm of MODELLER includes an automatic alignment 
followed by modelling the backbone, side chains and disul-
Þde bonds in accordance with the sequence alignment and 
other statistical potential related restraints embedded in the 
program. Finally, MODELLER Þnishes the model structures 
by a short simulated annealing molecular modelling using 
the Charmm22 molecular force field (http://salilab.org/
modeller/9v7/manual/node442.html). Additional features of 
MODELLER were utilized as follows: using multiple chains, 
involvement of symmetry constraint forcing identical geom-
etry for each chain and applying the Òdopehr_loopmodelÓ 
module to improve the ßexible loop regions. In the prepara-
tion of the template PDB Þles for modelling homotetramers 
the ÒMakeMultimer.pyÓ (http://watcut.uwaterloo.ca/cgi-bin/
makemultimer) python program was used to restore the sym-
metrical dimer coordinates where only the asymmetric unit 
was given together with the symmetry operator. Visualization 
of the structures was performed by the Visual Molecular 
Dynamics (VMD) program package (Humphrey et al. 1996). 
The quality assessment of the structures obtained by homol-
ogy modelling was performed by the program PROCHECK 
(Laskowski et al. 1993). The disulÞde bridge between the 
Cys69 residues of the chains was then reconstructed using 
VMD followed by a 1000 step energy minimization by the 
NAMD molecular dynamics program (Phillips et al. 2005) 
in vacuo.
Human tissue samples
All protocols for human heart sample procurement and han-
dling were approved for cardiac material from non-diseased 
donor hearts (Fig. 3). The human ventricle (female; age 32 
years) consisted of non-diseased endomyocardial tissue from 
hearts explanted to collect pulmonary and aortic valves for 
transplant surgery at the University of Szeged, Hungary. 
Samples from whom hearts were explanted received no medi-
cation except dobutamine, furosemide and plasma expand-
ers. All experimental protocols for sample procurement and 
handling were approved by the Ethical Review Board of the 
Medical Center of the University of Szeged (No. 51-57/1997 
OEJ) and conformed with the Helsinki Declaration of the 
World Medical Association. Cardiac tissue was stored in car-
dioplegic solution at 4 ¼C for 4-8 h. After tissue preservation 
and dissection procedures, the samples were frozen in liquid 
nitrogen and stored until immunohistochemistry.
Left-ventricular (LV) subendocardial tissue-slices (1-mm 
thickness) were obtained at the cardiac base. This heart was 
histologically normal and had normal expression of atrial na-
triuretic protein-levels. Contamination by vascular, neuronal 
and Þbrous tissue was excluded by the absent expression of 
calponin 1 (CNN1), ubiquitin thiolesterase (UCHL1) and 
collagen type-VI 1 (COL6A1). 
Immunofluorescence
Cryostat sections (10 µm) of non-diseased heart ventricle 
biopsies were treated with 0.5% collagenase, blocked with 
2% BSA in PBS and incubated for 2 h at room temperature 
with rabbit anti-TWIK1 and anti-TASK1 (Alomone; diluted 
1:100). Sections were then washed and incubated with Alexa 
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488-labeled anti rabbit IgG (1:400, Molecular Probes) for 
1 h at room temperature. Nuclei were stained with 1 µg/ml 
Hoechst 33258 in PBS for 10 min (method was modiÞed after 
Piecha et al. 1999). After rinsing, the sections were mounted 
with ßuorescent mounting medium (Dako), viewed and pho-
tographed with confocal laser scanning microscope using an 
Olympus Fluoview FV1000 (Olympus Life Science Europe 
GmbH, Hamburg, Germany). For each specimen (n=3 for 
each antibody staining) 60-80x Þeld images were selected 
from the zones that presented the greatest variability in the 
diameters of the tissues.
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